Prime Medicine, Inc.
PRME · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $182 | $42 | $188 | $185 |
| Short-Term Investments | $8 | $80 | $106 | $84 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $21 | $21 | $3 | $1 |
| Total Curr. Assets | $212 | $143 | $297 | $271 |
| Property Plant & Equip (Net) | $72 | $37 | $49 | $16 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $14 | $14 | $15 | $16 |
| Total NC Assets | $86 | $51 | $64 | $31 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $298 | $194 | $360 | $302 |
| Liabilities | – | – | – | – |
| Payables | $11 | $20 | $4 | $1 |
| Short-Term Debt | $4 | $9 | $12 | $7 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $7 | $0 | $0 | $0 |
| Other Curr. Liab. | $16 | $28 | $11 | $49 |
| Total Curr. Liab. | $38 | $56 | $27 | $58 |
| LT Debt | $37 | $4 | $17 | $3 |
| Deferred Rev, NC | $63 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $1 |
| Other NC Liab. | $6 | $0 | $0 | $0 |
| Total NC Liab. | $106 | $4 | $17 | $4 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $41 | $14 | $29 | $10 |
| Total Liabilities | $144 | $61 | $44 | $62 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $396 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$687 | -$491 | -$293 | -$171 |
| AOCI | $0 | -$0 | -$0 | -$0 |
| Other Equity | $840 | $624 | $610 | $15 |
| Total Equity | $153 | $133 | $316 | $240 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $298 | $194 | $360 | $302 |
| Net Debt | -$142 | -$28 | -$159 | -$175 |